Targeted liquid chromatography tandem mass spectrometry to quantitate wheat gluten using well-defined reference proteins.
Kathrin SchalkPeter KoehlerKatharina Anne ScherfPublished in: PloS one (2018)
Celiac disease (CD) is an inflammatory disorder of the upper small intestine caused by the ingestion of storage proteins (prolamins and glutelins) from wheat, barley, rye, and, in rare cases, oats. CD patients need to follow a gluten-free diet by consuming gluten-free products with gluten contents of less than 20 mg/kg. Currently, the recommended method for the quantitative determination of gluten is an enzyme-linked immunosorbent assay (ELISA) based on the R5 monoclonal antibody. Because the R5 ELISA mostly detects the prolamin fraction of gluten, a new independent method is required to detect prolamins as well as glutelins. This paper presents the development of a method to quantitate 16 wheat marker peptides derived from all wheat gluten protein types by liquid chromatography tandem mass spectrometry (LC-MS/MS) in the multiple reaction monitoring mode. The quantitation of each marker peptide in the chymotryptic digest of a defined amount of the respective reference wheat protein type resulted in peptide-specific yields. This enabled the conversion of peptide into protein type concentrations. Gluten contents were expressed as sum of all determined protein type concentrations. This new method was applied to quantitate gluten in wheat starches and compared to R5 ELISA and gel-permeation high-performance liquid chromatography with fluorescence detection (GP-HPLC-FLD), which resulted in a strong correlation between LC-MS/MS and the other two methods.
Keyphrases
- celiac disease
- liquid chromatography tandem mass spectrometry
- solid phase extraction
- simultaneous determination
- high performance liquid chromatography
- monoclonal antibody
- ms ms
- tandem mass spectrometry
- amino acid
- molecularly imprinted
- mass spectrometry
- irritable bowel syndrome
- protein protein
- liquid chromatography
- newly diagnosed
- end stage renal disease
- oxidative stress
- chronic kidney disease
- weight loss
- ejection fraction
- patient reported outcomes
- high resolution
- cancer therapy
- label free